AQR Capital Management - SALIX PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$3,355,000
-43.2%
29,186
-22.8%
0.01%
-56.2%
Q3 2014$5,904,000
+11.4%
37,786
-12.1%
0.02%
+14.3%
Q2 2014$5,302,000
+50.6%
42,986
+26.5%
0.01%
+27.3%
Q1 2014$3,521,000
+134.6%
33,986
+103.7%
0.01%
+175.0%
Q4 2013$1,501,000
+42.7%
16,686
-35.8%
0.00%
-20.0%
Q4 2012$1,052,00026,0000.01%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Zurcher Kantonalbank (Zurich Cantonalbank) 173,845$7,037,0000.28%
AMUNDI ASSET MANAGEMENT US, INC. 537,900$21,774,0000.09%
NOMURA HOLDINGS INC 127,903$5,175,0000.06%
GOLDMAN SACHS GROUP INC 386,458$15,641,0000.01%
AQR Capital Management 26,000$1,052,0000.01%
GOLDMAN SACHS GROUP INC 100,000$4,047,0000.00%
RATIONAL ADVISORS LLC 288$12,0000.00%
HSBC HOLDINGS PLC 5,448$220,0000.00%
View complete list of SALIX PHARMACEUTICALS INC shareholders